中华医学杂志（英文版）2025，Vol.138Issue(4)：452-458,7.DOI:10.1097/CM9.0000000000002990
Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis:A phase Ⅳ,24-week multicenter study
Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis:A phase Ⅳ,24-week multicenter study
Chao Quan 1Chunyang Li 2Qun Xue 3Huiqing Dong 4Fudong Shi 5Xinyue Qin 6Xinghu Zhang 7Feng Gao 8Hua Zhang 9Jiawei Wang 10Xueqiang Hu 11Hongyu Zhou 12Yueting Chen 13Jue Liu 14Wei Qiu 11Huan Yang 15Zheng Jiao 13Meini Zhang 16Baorong Zhang 17Guojun Tan 18Bitao Bu 19Tao Jin20
作者信息
- 1. Department of Neurology,Huashan Hospital,Shanghai Medical College,Fudan University,National Centre for Neurological Disorders,Shanghai 201206,China
- 2. Department of Neurology,The Affiliated Hospital of Inner Mongolia Medical University,Hohhot,Inner Mongolia 010050,China
- 3. Department of Neurology,The First Affiliated Hospital of Soochow University,Suzhou,Jiangsu 215006,China
- 4. Department of Neurology,Xuanwu Hospital,Capital Medical University,Beijing 100053,China
- 5. Department of Neurology,Tianjin Medical University General Hospital,Tianjin 300052,China
- 6. Department of Neurology,The First Affiliated Hospital of Chongqing Medical University,Chongqing 400016,China
- 7. Center of Neurology,Beijing Tiantan Hospital,Capital Medical University,Beijing 100070,China
- 8. Department of Neurology,Peking University First Hospital,Beijing1 00034,China
- 9. Department of Neurology,Beijing Hospital,Beijing 100730,China
- 10. Department of Neurology,Beijing Tongren Hospital,Capital Medical University,Beijing,100730 China
- 11. Department of Neurology,The Third Affiliated Hospital of Sun Yat-sen University,Guangzhou,Guangdong 510630,China
- 12. Department of Neurology,West China Hospital of Sichuan University,Chengdu,Sichuan 610041,China
- 13. Department of Pharmacy,Shanghai Chest Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200025,China
- 14. Medical Department,Sanofi Investment Co.,Ltd.,Shanghai 200040,China
- 15. Department of Neurology,Xiangya Hospital,Central South University,Changsha,Hunan 410008,China
- 16. Department of Neurology,The First Hospital of Shanxi Medical University,Taiyuan,Shanxi 030012,China
- 17. Department of Neurology,The Second Affiliated Hospital Zhejiang University School of Medicine,Hangzhou,Zhejiang 310009,China
- 18. Department of Neurology,The Second Hospital of Hebei Medical University,Shijiazhuang,Hebei 050000,China
- 19. Department of Neurology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,Hubei 430030,China
- 20. Department of Neurology,The First Hospital of Jilin University,Changchun,Jilin 130021,China
- 折叠
摘要
关键词
Teriflunomide/ABCG2 c.421C＞A/Multiple sclerosis/Non randomized/Population pharmacokinetics/SafetyKey words
Teriflunomide/ABCG2 c.421C＞A/Multiple sclerosis/Non randomized/Population pharmacokinetics/Safety引用本文复制引用
Chao Quan,Chunyang Li,Qun Xue,Huiqing Dong,Fudong Shi,Xinyue Qin,Xinghu Zhang,Feng Gao,Hua Zhang,Jiawei Wang,Xueqiang Hu,Hongyu Zhou,Yueting Chen,Jue Liu,Wei Qiu,Huan Yang,Zheng Jiao,Meini Zhang,Baorong Zhang,Guojun Tan,Bitao Bu,Tao Jin..Safety of teriflunomide in Chinese adult patients with relapsing multiple sclerosis:A phase Ⅳ,24-week multicenter study[J].中华医学杂志（英文版）,2025,138(4):452-458,7.
